Rosycap 5 Tablet
Marketer
Akumentis Healthcare Ltd
Salt Composition
Rosuvastatin (5mg)
Overview Rosycap 5 Tablet
Cardiostat 5mg belongs to the statin class of medications. Its purpose is to lower cholesterol levels, thereby mitigating the risk of cardiovascular events. High cholesterol, a fatty substance accumulating in blood vessels, narrows them, potentially causing heart attacks or strokes. Cardiostat 5mg is a frequently prescribed, generally well-tolerated medication suitable for long-term use. It can be taken with or without food, at any time of day, but consistency is key. While high cholesterol often presents without symptoms, discontinuing treatment elevates cholesterol, worsening the condition and increasing heart disease and stroke risk. Regular cholesterol monitoring is crucial. This medication forms one component of a comprehensive treatment plan that necessitates a balanced diet, regular physical activity, smoking cessation, responsible alcohol consumption, and weight management. Maintain a normal diet while minimizing high-fat foods. Common, usually transient side effects include myalgia, weakness, nausea, headache, and abdominal discomfort. Persistent symptoms, jaundice, or recurrent unexplained muscle pain necessitate immediate medical attention. Contraindications include liver disease; pregnancy and breastfeeding are also prohibited due to potential fetal harm. Diabetic patients should closely monitor their blood glucose levels, as this medication may cause elevated blood sugar.
Uses of Rosycap 5 Tablet
Managing elevated cholesterol levels to reduce heart attack and stroke risk.
Major Benefits of Rosycap 5 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Rosycap 5 Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Rosycap 5 Tablet can be taken with or without food, consistent timing is recommended.
Common Side effects of Rosycap 5 Tablet:
- Muscle pain
- Weakness
- Headache
- Abdominal pain
- Dizziness
- Joint pain
- Nausea
How to use Rosycap 5 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Rosycap 5 Tablets. Ingest the tablet whole; do not crush, chew, or break it. While Rosycap 5 Tablets can be taken with or without food, consistent timing is recommended for optimal results.
How Rosycap 5 Tablet works:
Rosycap 5 Tablets are statins, medications that reduce lipid levels. Their mechanism involves inhibiting HMG-CoA reductase, an enzyme crucial for cholesterol synthesis. This action decreases levels of LDL cholesterol and triglycerides while increasing HDL cholesterol.
SAFETY ADVICE
AlcoholCAUTION
Rosycap 5 Tablet should be taken with caution if alcohol is also being consumed. Seek medical advice before combining them.
PregnancyUNSAFE
Taking Rosycap 5 Tablet while pregnant poses a serious risk. Pregnant women should consult their physician, as research in both animals and humans indicates substantial harm to the fetus.
Breast feedingUNSAFE
Lactation and Rosycap 5 Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Driving ability is typically unaffected by Rosycap 5 Tablet.
KidneyCAUTION
Patients with kidney impairment should use Rosycap 5 Tablet cautiously, potentially requiring a modified dosage. Physician consultation is advised. Rosycap 5 Tablet is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Rosycap 5 Tablet cautiously, potentially requiring a modified dosage. Consult a physician for guidance. Rosycap 5 Tablet is contraindicated in individuals with severe or active liver disease.
What if you forget to take Rosycap 5 Tablet :
Should you forget to take a Rosycap 5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking consecutive doses within a 12-hour period.
Facts to Know About Rosycap 5 Tablet
| Label | Value |
|---|---|
| Type of Compound | Compounds based on the phenylpyrimidine scaffold |
| Potential for Dependence | None. |
| Medication Classification | HEART |
| Mechanism of Action | 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors |



